Sept 4 (Reuters) - Mayne Pharma Group Ltd (MYX) :
- MAYNE PHARMA EXECUTES ASSET PURCHASE AGREEMENT WITH NOVAN AND EPI HEALTH FOR RHOFADE®
- TERMS OF DEAL ARE US$8 MILLION IN CASH AT CLOSING PLUS ASSOCIATED CURE COSTS NOT TO EXCEED US$1.5 MILLION
Sept 4 (Reuters) - Mayne Pharma Group Ltd (MYX) : MAYNE PHARMA...
Add to My Watchlist
What is My Watchlist?